According to the European Center for Disease Prevention and Control (ECDC), annual influenza vaccination is the most effective way to prevent seasonal influenza; however, vaccination coverage in Europe is still low compared to European countries.
The 75% target set by the World Health Organization (WHO). One of the problems is the barriers some populations face in influenza vaccination campaigns. This is the case for patients with non-communicable diseases (NCDs).In this regard, Viatris has developed a
Study investigates motivations and difficulties with influenza vaccinationVaccinated and unvaccinated NCD patients in France, Italy, Spain, Germany, Poland, Belgium, Portugal and the Czech Republic.Although overall attitudes toward vaccines are positive,
Three-quarters of respondents have a favorable opinionData indicate that exposure to vaccination information is still quite lacking.Most of the
Unvaccinated patients not exposed to relevant information About vaccines. Therefore, according to these data, consciousness remains a significant challenge. Faced with this situation, Viatris intends to increase its efforts to promote the importance of vaccination.
Breaking down barriers in flu campaigns
In an effort to improve these barriers in influenza campaigns, Viatris also announced that its Influvac Tetra vaccine will be available in Spain during the next 2023-2024 influenza season.Therefore, to protect public health, pharmaceutical company Viatris announced Shipment of quadrivalent influenza vaccine to Spain for the 2023-2024 season. The action is part of its commitment to ensure vaccines are available as early as possible, even before the flu season begins. On the other hand, it is worth remembering that the changes brought about by this campaign are expected to improve the protection of the population. Especially the child population. Therefore, now, healthy children aged 6 months to 5 years are prioritized for vaccination. Similarly, the age range for vaccination of the elderly also starts from 60 years old, revising the previous reference value of 65 years old. The care needs of people who smoke are also highlighted. These adjustments are designed to meet current needs and break down barriers in influenza campaigns.
Source link
